Clinical trial
Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung…
NCT00145418 · Oncology Specialists, S.C., Other · Terminated
Key facts
| NCT number | NCT00145418 |
|---|---|
| Title | Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer |
| Official title | Phase 2 Study Evaluating the Safety and Efficacy of Eloxatin (Oxaliplatin) and Docetaxel as First-line Therapy of Stage IV or IIIB Unresectable Non-Small Cell Lung Cancer |
| Lead sponsor | Oncology Specialists, S.C., Other |
| Collaborators | Sanofi-Synthelabo Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Oxaliplatin + Docetaxel |
| Enrollment | 15 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 30, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: